Adaptin Bio (APTN) Debt to Equity (2024 - 2026)
Adaptin Bio (APTN) reported Debt to Equity of -$0.14 for Q1 2026, down 1.99% sequentially from -$0.13 in Q4 2024.
Adaptin Bio (APTN) Debt to Equity (2024 - 2026) Analysis & Trends
Adaptin Bio has disclosed Debt to Equity across 2 years of filings, most recently posting -$0.14 for Q1 2026.
- Quarterly Debt to Equity changed N/A year-over-year to -$0.14 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.14 (changed N/A YoY) and the FY2024 annual result came in at -$0.13, changed N/A from the prior year.
- Debt to Equity fell to -$0.14 in Q1 2026, from -$0.13 in the prior quarter.
- Across five years, Debt to Equity topped out at -$0.13 in Q4 2024 and bottomed at -$0.14 in Q1 2026.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.14 |
| Dec 31, 2024 | -0.13 |